Literature DB >> 15507434

Sumoylation of MITF and its related family members TFE3 and TFEB.

Arlo J Miller1, Carmit Levy, Ian J Davis, Ehud Razin, David E Fisher.   

Abstract

MITF and its related family members TFE3 and TFEB heterodimerize with each other, recognize the same DNA sequences, and are subject to many of the same post-translational modifications. We show that lysine residues within conserved small ubiquitin-like modifier (SUMO) consensus sites in these family members are subject to SUMO modification. Mutation of these sites significantly affects the transcriptional activity of MITF but does not alter dimerization, DNA binding, stability, or nuclear localization. Mutagenesis reducing the number of MITF binding sites in the promoter of TRPM1 from three to one eliminated the difference in transcriptional activity between the MITF mutants. Among other MITF target gene promoter constructs, differences in transcriptional activity between wild type and non-sumoylatable MITF were only seen in promoters with multiple MITF binding sites. These data support a synergy control model in which the functional consequences of MITF sumoylation depend on promoter context. Sumoylation, thus, provides a possible mechanism for altering the effects of MITF by affecting the target genes that it activates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507434     DOI: 10.1074/jbc.M411757200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

Review 3.  TRPM channels: same ballpark, different players, and different rules in immunogenetics.

Authors:  Ammad Ahmad Farooqi; Mohammed Khalid Javeed; Zeeshan Javed; Asma M Riaz; Shahzeray Mukhtar; Sehrish Minhaj; Sana Abbas; Shahzad Bhatti
Journal:  Immunogenetics       Date:  2011-09-20       Impact factor: 2.846

4.  MITF and cell proliferation: the role of alternative splice forms.

Authors:  Keren Bismuth; Dragan Maric; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-10

5.  SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription.

Authors:  Jens Tiefenbach; Natalia Novac; Miryam Ducasse; Maresa Eck; Frauke Melchior; Thorsten Heinzel
Journal:  Mol Biol Cell       Date:  2006-01-18       Impact factor: 4.138

Review 6.  The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Authors:  Akinori Kawakami; David E Fisher
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

7.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

8.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

9.  A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment.

Authors:  Ann-Kristin Molvaersmyr; Thomas Saether; Siv Gilfillan; Petra Isabel Lorenzo; Heidi Kvaløy; Vilborg Matre; Odd Stokke Gabrielsen
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

10.  miR-148 regulates Mitf in melanoma cells.

Authors:  Benedikta S Haflidadóttir; Kristín Bergsteinsdóttir; Christian Praetorius; Eiríkur Steingrímsson
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.